MYCELX Technologies Corporation

As of December 31, 2025, MYCELX Technologies Corporation has 24.36M shares outstanding.

As of December 31, 2025, MYCELX Technologies Corporation trades at an EV/EBITDA multiple of 2.33 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.04 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 2.33 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses.

As of December 31, 2025, MYCELX Technologies Corporation maintains a current ratio of 2.45, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 22.28, indicating elevated leverage, while an interest coverage ratio of 12.87 demonstrates strong ability to service its debt obligations.

Over the twelve months ended December 31, 2025, MYCELX Technologies Corporation posted a return on equity (ROE) of 6.12, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 2.86 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.57, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.19, useful for judging operating efficiency across full business cycles. Inventory turnover of 1.96 indicates how many times MYCELX Technologies Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures cover the twelve months ended December 31, 2025. That works out to an effective tax rate of 0.89, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

Over the twelve months ended December 31, 2025, MYCELX Technologies Corporation posted a gross margin of 47.83, reflecting its pricing power and cost economics. The operating margin of 1.64 and net profit margin of 2.84 provide insight into operational efficiency.

As of December 31, 2025, MYCELX Technologies Corporation has an Altman Z-Score of -4.88, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.